P59594 (SPIKE_SARS) Severe acute respiratory syndrome coronavirus (SARS-CoV)
Spike glycoprotein UniProtKBInterProInteractive Modelling
1255 aa; Sequence (Fasta) ;
26 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
83 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles |
Heteromer Q9BYF1; | 99.66 | 9×NAG; 7×NAG; 11×NAG; 6×NAG; | |||
| Structure of the SARS-CoV spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fr… |
Heteromer | 99.63 | 12×NAG; 3×NAG; 3×NAG; 36×NAG; | |||
| SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) |
Heteromer | 99.72 | 27×NAG; 9×NAG; 1×NAG; 1×NAG; 17×NAG; | |||
| SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) |
Heteromer | 99.71 | 21×NAG; 6×NAG; 4×NAG; 6×NAG; 16×NAG; | |||
| Cryo-EM structure of SARS-CoV-1 RBD in complex with W328-6H2 (local refinement) |
Heteromer | 100.0 | 5×NAG; | |||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer Q9BYF1; | 100.0 | ||||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer Q9BYF1; | 100.0 | ||||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… |
Heteromer Q9BYF1; | 100.0 | ||||
| Trimer state of SARS-CoV Spike protein complexed with antibody PW5-535 |
Heteromer | 99.72 | ||||
| Structure of SARS-CoV Spike protein complexed with antibody PW5-5 |
Heteromer | 99.72 | ||||
| Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047 |
Heteromer | 99.82 | 47×NAG; | |||
| Monomer state of SARS-CoV Spike protein complexed with antibody PW5-535 |
Heteromer | 99.82 | ||||
| Structure of a proteolitically resistant core from the severe acute respiratory syndrome coronaviru… |
Heteromer | 100 | 3×GOL; | |||
| Crystal structure of the SARS-CoV Spike protein fusion core |
Heteromer | 100.0 | ||||
| A structure-based mechanism of SARS virus membrane fusion |
Heteromer | 100 | 2×NA; | |||
| Structure of a Proteolytically Resistant Core from the Severe Acute Respiratory Syndrome Coronaviru… |
Heteromer | 100 | ||||
| Crystal structure of nanobody Nb70 with SARS-CoV RBD |
Heteromer | 100 | 2×NAG; | |||
| Crystal structure of SARS-CoV receptor binding domain in complex with human antibody BIOLS56 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-1 RBD in complex with nanobody aSR29 and aSR347 |
Heteromer | 99.49 | 2×NAG; | |||
| The local refined map of SARS-CoV Spike protein complexed with antibody PW5-5 |
Heteromer | 100 | ||||
| Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 |
Heteromer P0DTC2; Q9BYF1; | 100 | 3×NAG; 2×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG; | |||
| Crystal structure of chimeric omicron RBD (strain XBB.1) complexed with human ACE2 |
Heteromer Q9BYF1; | 86.98 | 2×NAG; 3×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG; | |||
| Crystal structure of chimeric omicron RBD (strain XBB.1.5) complexed with human ACE2 |
Heteromer Q9BYF1; | 86.91 | 2×NAG; 1×NAG; 1×ZN; 1×CL; 3×NAG; | |||
| Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody |
Heteromer Q8N355; | 100 | 1×PO4; 1×NAG; | |||
| Crystal structure of SARS-CoV RBD and horse ACE2 |
Heteromer F6V9L3; | 100 | 1×NAG; 2×NAG; | |||
| Crystal structure of SARS spike protein receptor binding domain in complex with a neutralizing anti… |
Heteromer Q65ZC9; | 100 | 4×CL; | |||
| Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 |
Heteromer | 100.0 | 1×NAG; 1×PO4; 1×NAG; | |||
| The structure of fox ACE2 and SARS-CoV RBD complex |
Heteromer A0A3Q7RAT9; | 100 | 1×ZN; | |||
| Cryo-EM structure of SARS-CoV spike protein in complex with three nAbs X01, X10 and X17 |
Heteromer | 100 | 2×NAG; | |||
| Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH… |
Heteromer | 100 | 1×NAG; | |||
| Structure of the SARS-CoV receptor binding domain in complex with the human neutralizing antibody F… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with sea lion ACE2 |
Heteromer A0A6J2EID0; | 100 | 1×ZN; | |||
| Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with minke whale ACE2 |
Heteromer A0A452CBT6; | 100 | 1×ZN; | |||
| Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … |
Heteromer Q9BYF1; | 98.85 | 1×ZN; 1×CL; | |||
| Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor |
Heteromer Q9BYF1; | 100.0 | 1×NAG; 4×NAG; 1×ZN; 1×CL; | |||
| X-ray crystal structure of the SARS coronavirus spike receptor binding domain in complex with F26G1… |
Heteromer Q7TS98; Q8CGS2; | 100.0 | ||||
| Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … |
Heteromer Q9BYF1; | 98.28 | 1×ZN; 1×CL; | |||
| Local CryoEM structure of the SARS-CoV S2P in complex with BD55-3152 Fab |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… |
Heteromer Q56NL1; Q9BYF1; | 100.0 | 5×NDG; 2×ZN; 2×CL; 1×NAG; | |||
| Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… |
Heteromer Q56NL1; Q9BYF1; | 98.27 | 5×NDG; 2×ZN; 2×CL; 1×NAG; | |||
| Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… |
Heteromer Q56NL1; Q9BYF1; | 100.0 | 1×ZN; 1×CL; | |||
| Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … |
Heteromer Q56NL1; Q9BYF1; | 98.27 | 1×ZN; 1×CL; | |||
| Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… |
Heteromer Q56NL1; Q9BYF1; | 98.84 | 5×NDG; 2×ZN; 2×CL; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV RBD in complex with rabbit ACE2 |
Heteromer G1TEF4; | 100 | 1×ZN; | |||
| Crystal Structure of the Human Coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1 |
Heteromer | 100 | ||||
| A structure-based mechanism of SARS virus membrane fusion | homo-4-mer | 100 | 2×CL; | |||
| Cryo-EM Structure of Spike Glycoprotein from Civet Coronavirus SZ3 in Closed Conformation | homo-3-mer | 98.71 | 7×NAG; 11×NAG; 9×NAG; 6×NAG; 6×NAG; 9×NAG; 3×EIC; | |||
| SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, one S1 CTD in an upwards conformation | homo-3-mer | 99.72 | 9×NAG; 2×NAG; 8×NAG; 15×NAG; | |||
| SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation | homo-3-mer | 99.72 | 5×NAG; 7×NAG; 9×NAG; 13×NAG; | |||
| SARS Spike Glycoprotein, Stabilized variant, C3 symmetry | homo-3-mer | 99.66 | 6×NAG; 3×NAG; 18×NAG; | |||
| SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation | homo-3-mer | 99.72 | 19×NAG; 3×NAG; 5×NAG; 7×NAG; | |||
| SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, C3 symmetry | homo-3-mer | 99.72 | 9×NAG; 2×NAG; 8×NAG; 15×NAG; | |||
| SARS Spike Glycoprotein, Trypsin-cleaved, Stabilized variant, two S1 CTDs in an upwards conformation | homo-3-mer | 99.72 | 9×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG; | |||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conforma… | homo-3-mer | 100.0 | ||||
| Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conforma… | homo-3-mer | 100.0 | ||||
| Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-2 Conf… | homo-3-mer | 99.81 | 3×NAG; 42×NAG; 3×BLA; 3×EIC; | |||
| Structure of SARS-CoV-1 Spike Protein with Engineered x3 Disulfide (D414C and V969C), Locked-1 Conf… | homo-3-mer | 99.81 | 42×NAG; 3×EIC; | |||
| Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation | homo-3-mer | 100.0 | 32×NAG; | |||
| Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Locked-2 Conf… | homo-3-mer | 99.8 | 3×NAG; 39×NAG; | |||
| Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Closed Confor… | homo-3-mer | 99.78 | 21×NAG; | |||
| Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-1 Conf… | homo-3-mer | 99.81 | 3×EIC; 42×NAG; 3×BLA; | |||
| Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Co… | homo-3-mer | 99.8 | 3×EIC; 46×NAG; 3×BLA; | |||
| Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Co… | homo-3-mer | 99.81 | 3×NAG; 39×NAG; 3×BLA; 3×EIC; | |||
| Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Closed Confor… | homo-3-mer | 99.8 | 1×NAG; 37×NAG; | |||
| Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Closed Conformation | homo-3-mer | 100.0 | 18×NAG; | |||
| SARS CoV Spike protein, Open conformation | homo-3-mer | 100.0 | 23×NAG; | |||
| Structure of SARS-CoV spike glycoprotein | homo-3-mer | 100.0 | ||||
| Prefusion structure of SARS-CoV spike glycoprotein, conformation 2 | homo-3-mer | 99.81 | ||||
| Prefusion structure of SARS-CoV spike glycoprotein, conformation 1 | homo-3-mer | 99.81 | 42×NAG; | |||
| SARS CoV Spike protein, Closed C1 conformation | homo-3-mer | 99.9 | 3×NAG; 3×EIC; 27×NAG; | |||
| SARS CoV Spike protein, Closed C3 conformation | homo-3-mer | 99.9 | 3×NAG; 3×EIC; 30×NAG; | |||
| SARS-CoV spike glycoprotein | homo-3-mer | 100.0 | ||||
| Post-fusion structure of SARS-CoV spike glycoprotein | homo-3-mer | 100.0 | 24×NAG; | |||
| Post-fusion hairpin conformation of the sars coronavirus spike glycoprotein | homo-3-mer | 100.0 | 6×CL; | |||
| Solution Structure of the SARS-Coronavirus HR2 Domain | homo-3-mer | 100 | ||||
| A structure-based mechanism of SARS virus membrane fusion | homo-3-mer | 100 | ||||
| A structure-based mechanism of SARS virus membrane fusion | homo-2-mer | 100 | ||||
| Crystal structure of SARS spike protein receptor binding domain | homo-2-mer | 100 | ||||
| Structure of the N-terminal domain (NTD)of SARS-CoV spike protein | monomer | 99.26 | 1×NAG; 1×NAG; | |||
| NMR Structure and Localization of a Large Fragment of the SARS-CoV Fusion Protein: Implications in … | monomer | 98.44 | ||||
| Solution structure of Fusion peptide | monomer | 94.74 | ||||
| Solution Structure of Pre Transmembrane domain | monomer | 100 | ||||
| Solution Structure of Internal Fusion Peptide | monomer | 100 | ||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7cn8.1.A | homo-3-mer | 0.69 | 76.65 | |||
| 6zgf.1.A | homo-3-mer | 0.68 | 76.14 | |||
| 7cwu.1.I | monomer | 0.68 | 77.72 | |||
| 7wt7.1.C | monomer | 0.67 | 1×NAG; | 75.94 | ||
| 7fg3.1.A | monomer | 0.54 | 77.72 | |||